Charles Dolladille

15PUBLICATIONS
47CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Work integrated learning (incl. internships)Cardiology (incl. cardiovascular diseases)AutoimmunityImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jun 05, 2026
Ischaemic stroke and 5-fluorouracil or capecitabine: A systematic review and meta-analysis of harms and a retrospective study of the WHO pharmacovigilance database.

|May 19, 2026
Influence of learning activities and background characteristics on pharmacology exam success in second-year medical students at a French university: the Pharmaquest study.

|Sep 27, 2025
Association Between the Renin-Angiotensin System and Ibrutinib-Related Cardiovascular Adverse Events: A Translational Cohort Study.

Jonaz Font, Amir Hodzic, Angélique Da-Silva

|Jun 26, 2025
Immune checkpoint inhibitor-associated myocarditis: a novel risk score.

John R Power, Charles Dolladille, Benay Ozbay

|Apr 24, 2025
Identification of anticancer drugs associated to cancer therapy-related cardiac dysfunction: a VigiBase® disproportionality analysis.

Damien Legallois, Angélique Da Silva, Joachim Alexandre

|Sep 19, 2024
Is ibrutinib-related atrial fibrillation dose dependent? Insights from an individual case level analysis of the World Health Organization pharmacovigilance database.

Joachim Alexandre, Jonaz Font, Da-Silva Angélique

Pageof 3

Frequent Collaborators

4 joint publications

Pierre-Marie Morice

4 joint publications

Joachim Alexandre

3 joint publications

Damien Legallois

3 joint publications

Jonaz Font